Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication

Nadyr Damasceno1,2 Ophthalmology Department, Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil

Soraya Horowitz1,2 Ophthalmology Department, Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil

Eduardo Damasceno3 Department of Ophthalmology, Universidade Federal Fluminense, Niteroi, BrazilCorrespondence[email protected]

References

DaySAcquahKMruthyunjayaPGrossmanDSLeePPSloanFAOcular complications after anti-vascular endothelial growth factor therapy in Medicare patients with age-related macular degenerationAm J Ophthalmol2011152226627221664593
PubMed Web of Science ®Google Scholar
FungAERosenfeldPJReichelEThe International Intravitreal Bevacizumab Safety Survey: using the internet to assess drug safety worldwideBr J Ophthalmol200690111344134916854824
PubMed Web of Science ®Google Scholar
GulatiNForooghianFLiebermanRJabsADVascular endothelial growth factor inhibition in uveitis: a systemic reviewBr J Ophthalmol20119516216520494915
PubMed Web of Science ®Google Scholar
SatoTEmiKIkedaTSevere intraocular inflammation after intravitreal injection of bevacizumabOphthalmology2010117351251320031229
PubMed Web of Science ®Google Scholar
WickremasingheSSMichalovaKGilhotraJAcute intraocular inflammation after intravitreous injections of bevacizumab for treatment of neovascular age related macular degenerationOphthalmology2008115111911191518672291
PubMed Web of Science ®Google Scholar